Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
Status: Terminated
Location: See all (36) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Subject is male or female \> 18 years of age.
• Subject has an untreated primary melanoma.
• OR
• Subject has high suspicion of primary malignancy of melanoma based on skin exam or imaging.
• Subject understands the study procedures and is able to provide informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigator.
Locations
United States
Arkansas
CARTI Cancer Center
Little Rock
California
Alliance Research Centers
Laguna Hills
Palmtree Clinical Research, Inc
Palm Springs
San Fernando Valley Health Institute
Van Nuys
Connecticut
Middlesex Hospital
Middletown
The Stamford Hospital
Stamford
Florida
Direct Helpers Research Center
Hialeah
East Coast Institute for Research, LLC
Jacksonville
Mid-Florida Hematology and Oncology Center
Orange City
Olympian Clinical Research
Tampa
Georgia
Balanced Life Health Care Solutions, LLC
Buford
IACT Health (DBA John B. Amos Cancer Center)
Columbus
Illinois
PMG Research, INC
Downers Grove
Carle Cancer Center NCI
Urbana
Indiana
Franciscan Health Indianapolis
Indianapolis
Kentucky
St. Elizabeth Medical Center
Edgewood
Maryland
DermAssociates, PC
Rockville
Michigan
Cancer Research Consortium of West Michigan
Grand Rapids
Minnesota
HealthPartner Institute
Bloomington
Mississippi
MediSync Clinical Research
Petal
North Carolina
East Carolina University Brody School of Medicine
Greenville
PMG Research of Rocky Mount, LLC
Rocky Mount
Nebraska
Somnos Laboratories, Inc.
Lincoln
Cancer Alliance of Nebraska
Omaha
Ohio
MediSync Clinical Research
Dayton
South Carolina
Spartanburg Regional Healthcare District
Spartanburg
Lexington Medical Center
West Columbia
Tennessee
The Jackson Clinic Professional Association
Jackson
Texas
MediSync Clinical Research
Austin
Austin Institute for Clinical Research
Pflugerville
MediSync Clinical Research
Pflugerville
Aim Trials, LLC
Plano
Washington
Wenatchee Valley Hospital
Wenatchee
Wisconsin
Dean Clinic - Fort Atkinson Specialty Services
Fort Atkinson
HSHS St Vincent Hospital Regional Cancer Center
Green Bay
ProHealth Care
Oconomowoc
Time Frame
Start Date: 2019-01-10
Completion Date: 2020-03-24
Participants
Target number of participants: 348
Treatments
Melanoma
Subjects with clinically confirmed melanoma or high suspicion of a primary malignancy of melanoma based on skin exam or imaging and who are treatment naive will provide a blood sample at time of enrollment. No additional blood draws will occur.
Authors
Rodney Basler, Kathleen Yost, Peyman Ghasri, William Randall, Morrisa Baskin, Rambod Rouhbakhsh, Abderrahim Khomani, Santosh Nair, Meghana Raghavendra, Steven Madden, Timothy Wassenaar, Kamal Patel, Amit Sanyal, Nasreen Vohra, Gretchen Crook, Thomas Munyon, Nadia Cameron, Edward Lain, Benjamin Lockshin, Andrew Pippas, Kellie Wallace-Wilding, Robert Levy, Anurekha Chadha, Scott Warren, Kenneth Deck, Jeffrey Suchniak, Anthony Jaslowski, Nasir Shahab, Jose Mendez, Mukesh Delvadiya, Nagendra Natarajan, Michael Milligan
Related Therapeutic Areas
Sponsors
Leads: Exact Sciences Corporation